Interferon regulatory factor-1 is required for a T helper 1 immune response in vivo

被引:262
|
作者
Lohoff, M
Ferrick, D
Mittrucker, HW
Duncan, GS
Bischof, S
Rollinghoff, M
Mak, TW
机构
[1] UNIV TORONTO,AMGEN RES INST,TORONTO,ON M5G 2M9,CANADA
[2] UNIV TORONTO,DEPT IMMUNOL,TORONTO,ON M5G 2M9,CANADA
[3] UNIV TORONTO,DEPT MED BIOPHYS,TORONTO,ON M5G 2M9,CANADA
[4] UNIV ERLANGEN NURNBERG,INST KLIN MIKROBIOL & IMMUNOL,D-91054 ERLANGEN,GERMANY
[5] UNIV CALIF DAVIS,SCH VET MED,DEPT PATHOL,DAVIS,CA 95616
[6] UNIV CALIF DAVIS,SCH VET MED,DEPT MICROBIOL,DAVIS,CA 95616
[7] UNIV CALIF DAVIS,DEPT IMMUNOL,SCH VET MED,DAVIS,CA 95616
基金
英国医学研究理事会; 美国国家卫生研究院;
关键词
D O I
10.1016/S1074-7613(00)80444-6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The transcription factor interferon regulatory factor-1 (IRF-1) mediates the effects of IFN. No information exists on its role in lymphokine production. Protection against the intracellular pathogen Leishmania major depends on a Th1 response. Here, we show that CD4(+) T cells from Leishmania-infected mice lacking one (+/-) or both (-/-) alleles of the IRF-1 gene developed a profound, gene dose-dependent decrease in IFN gamma production. IRF-1(-/-) mice showed dramatically exacerbated Leishmaniasis. They produced increased Leishmania-specific IgG1 and IgE, and their CD4(+) T cells produced increased IL-4, characteristics of the nonprotective Th2 response. In eel transfer experiments, IRF-1(-/-) CD4(+) T cells mounted normal Th1 responses. However, the ability of IRF-1(-/-) mice to produce IL-12 was severely compromised. Thus, IRF-1 is a determining factor for Th1 responses.
引用
收藏
页码:681 / 689
页数:9
相关论文
共 50 条
  • [11] Interferon regulatory factor-1 is a key transcription factor in murine beta cells under immune attack
    C. Gysemans
    H. Callewaert
    F. Moore
    M. Nelson-Holte
    L. Overbergh
    D. L. Eizirik
    C. Mathieu
    Diabetologia, 2009, 52 : 2374 - 2384
  • [12] Interferon regulatory factor-1 is a key transcription factor in murine beta cells under immune attack
    Gysemans, C.
    Callewaert, H.
    Moore, F.
    Nelson-Holte, M.
    Overbergh, L.
    Eizirik, D. L.
    Mathieu, C.
    DIABETOLOGIA, 2009, 52 (11) : 2374 - 2384
  • [13] Identification of proteins immunologically related to interferon regulatory factor-1 that bind with interferon regulatory factor element
    Contente, Sara
    Attard, Frank A.
    Friedman, Robert M.
    JOURNAL OF INFECTIOUS DISEASES, 2006, 194 : S27 - S32
  • [14] Interferon regulatory factor-1 eradicates tumors by inducing immune responses through T-cell stimulation and regulatory T-cell inhibition
    Klages, Katjana
    Ksienzyk, Antje
    Hauser, Hansjoerg
    Kroeger, Andrea
    CYTOKINE, 2008, 43 (03) : 306 - 306
  • [15] Interferon regulatory factor-1, a potential target for tumor therapy
    Kröger, A
    Kirchhoff, S
    Hauser, H
    EUROPEAN CYTOKINE NETWORK, 1998, 9 (03) : 402 - 402
  • [16] Transcriptional regulation of human papillomaviruses by interferon regulatory factor-1
    Tyring, S
    Arany, I
    Whitehead, W
    Grattendick, K
    Hoskins, L
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2001, 117 (02) : 523 - 523
  • [17] The association of interferon regulatory factor-1 (IRF-1) promoter polymorphism with HCV infection and interferon treatment response.
    Promrat, K
    Tang, G
    Dai, W
    Gonzalez, C
    Tong, XM
    Lan, Z
    Ghany, M
    Alter, HJ
    Rotter, JI
    Hoofnagle, JH
    Yang, H
    Liang, TJ
    HEPATOLOGY, 2002, 36 (04) : 282A - 282A
  • [18] Functional dissection of the transactivation domain of interferon regulatory factor-1
    Kim, EJ
    Park, CH
    Park, JS
    Um, SJ
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 304 (02) : 253 - 259
  • [19] Interferon regulatory factor-1, interferon-β, and reovirus-induced myocarditis
    Azzam-Smoak, K
    Noah, DL
    Stewart, MJ
    Blum, MA
    Sherry, B
    VIROLOGY, 2002, 298 (01) : 20 - 29
  • [20] Regulation of interferon responses in medulloblastoma cells by interferon regulatory factor-1 and -2
    Park, KC
    Shimizu, K
    Hayakawa, T
    Tanaka, N
    BRITISH JOURNAL OF CANCER, 1998, 77 (12) : 2081 - 2087